Abstract:Granuloma faciale is a rare dermatosis of chronic course, benign, usually
asymptomatic, first described in 1945 by Wingley. It is characterized by the
appearance of well-defined, single or multiple papules, plaques and nodules,
predominantly located in sun-exposed areas, especially the face. In this work we
report the case of a female patient, 58 years old, evolving for ten years with
multiple erythematous-brownish and asymptomatic papules on the face, whose
histological examination confirmed the diagnosis of … Show more
“…The specificity of the disease in terms of its refraction to treatment constitutes a challenge for doctors and causes a psychological problem for the patient. However, more recent studies have shown good results after four months with topical tacrolimus 0.1% [10]. Meanwhile, other studies have shown good and promising results with intralesional rituximab [11].…”
Granuloma faciale is a rare chronic skin disorder characterized by asymptomatic papules, nodules, and plaques on the face. Although its pathogenesis is unknown, researchers have suggested that one of the main causative factors may be sun exposure, as lesions are aggravated by sunlight and favor light-exposed areas. Herein, we are reporting the case of an adult female patient with keloidal granuloma faciale treated with a combination of several treatment methods with no improvement and a relapse. In this case, we attempted to highlight the difficulties that the doctor faces in treating the disease and to share the medical literature of our treatment experience.
“…The specificity of the disease in terms of its refraction to treatment constitutes a challenge for doctors and causes a psychological problem for the patient. However, more recent studies have shown good results after four months with topical tacrolimus 0.1% [10]. Meanwhile, other studies have shown good and promising results with intralesional rituximab [11].…”
Granuloma faciale is a rare chronic skin disorder characterized by asymptomatic papules, nodules, and plaques on the face. Although its pathogenesis is unknown, researchers have suggested that one of the main causative factors may be sun exposure, as lesions are aggravated by sunlight and favor light-exposed areas. Herein, we are reporting the case of an adult female patient with keloidal granuloma faciale treated with a combination of several treatment methods with no improvement and a relapse. In this case, we attempted to highlight the difficulties that the doctor faces in treating the disease and to share the medical literature of our treatment experience.
We present a 40-year-old woman with a one-year history of a solitary and asymptomatic facial lesion. On physical examination a slightly infiltrated, smooth red to brown nodule was seen at the left malar region. A biopsy established the diagnosis of granuloma faciale. After two-months therapy with topical tacrolimus 0,1%, nodule was resolved.
Case synopsisA 40-year-old woman presented with a one-year history of a solitary and asymptomatic facial lesion. On physical examination a slightly infiltrated, red to brown nodule was seen at the left malar region (Figure 1). The borders of the nodule were well defined; it had a smooth surface with dilated follicular ostia. The patient's medical history was unremarkable. Figure 1. Slightly infiltrated, red to brown nodule at left malar region.Histopathologic examination demonstrated, a dense, polymorphous, inflammatory cell infiltrate in the mid and deep dermis. The epidermis was spared and a Grenz zone in the upper dermis was present (Figure 2).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.